TIMI Study Finds New Class of Anti-Clotting Drug Reduced Bleeding Events Compared with Standard of Care in Patients with Atrial Fibrillation (IMAGE)

Brigham and Women's Hospital

TIMI Study Finds New Class of Anti-Clotting Drug Reduced Bleeding Events Compared with Standard of Care in Patients with Atrial Fibrillation

Caption

Christian Ruff, MD, MPH, director of General Cardiology within the Cardiovascular Division at Brigham and Women’s Hospital and principal investigator of the AZALEA-TIMI 71 Study.

Credit

Brigham and Women's Hospital

Usage Restrictions

N/A

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.